Research gaps for children who are HIV-exposed but uninfected: outcomes of a research prioritisation workshop
Related Experiment Video
Updated: Sep 11, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Catherine J Wedderburn1, Ceri Evans2, Elaine J Abrams3
1Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; Neuroscience Institute, University of Cape Town, Cape Town, South Africa; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Abstract:
Globally, 16 million children are HIV-exposed but uninfected (HEU), with health disparities when compared with children who are HIV-unexposed. To identify current challenges, a research prioritisation exercise was conducted through an online survey and in-person workshop with diverse stakeholders, with the aim of identifying the top ten scientific priorities related to children who are HEU. Among 104 survey respondents (46% from Africa; 37% from Europe; 15% from the region of the Americas; and 2% from South-East Asia), 271 research questions were submitted. Workshop attendees (n=35) refined and prioritised questions through discussion and consensus. The highest research priority was identifying strategies to reduce morbidity and mortality and to improve growth and neurodevelopment among children who are HEU. Other research questions included: defining the underlying causes of health disparities; identifying clinically vulnerable mother-infant pairs through screening; documenting life course outcomes; defining the contribution of antiretrovirals to health disparities; identifying clinically important immune perturbations; understanding which infections should be prevented, and how; exploring intergenerational effects; defining meaningful health disparities; and characterising drivers of immune abnormalities. Participants also identified several methodological considerations and strategic approaches to advance the field. Coordinated action between communities, researchers, clinicians, policy makers, and funders is now required to conduct high-quality research to address these priority needs, with a particular focus on regions with high HIV prevalence.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bias in Epidemiological Studies
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...

